Cargando…
Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Hodgkin's Lymphoma, COVID Vaccination, and Appropriate Investigation Time
Autores principales: | Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380791/ https://www.ncbi.nlm.nih.gov/pubmed/35982819 http://dx.doi.org/10.4103/ijnm.ijnm_151_21 |
Ejemplares similares
-
Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Hodgkin's Lymphoma: Diagnostic Challenge during COVID Vaccination
por: Usmani, Sharjeel, et al.
Publicado: (2021) -
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of recurrence carcinoma cervix
por: Wiwanitkit, Viroj
Publicado: (2014) -
Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of primary pulmonary angiosarcomas
por: Krishnamurthy, Arvind, et al.
Publicado: (2015) -
Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in evaluation of residual intramuscular myxoma
por: Zade, Anand, et al.
Publicado: (2015) -
Extramedullary Plasmacytoma of the Gallbladder Detected on Fluorine 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
por: Fakhri, Asif Ali, et al.
Publicado: (2016)